Blog Feed: International Stem Cell Corporation Blog

International Stem Cell Corporations Announces 2011 Financial Results

Published on 2012-03-20 10:01:00

CARLSBAD, California – March 20, 2012 - International Stem Cell Corporation (OTCBB: ISCO) www.internationalstemcell.com > read more

International Stem Cell Corporation Completes $5 Million Financing and Elects Jim Berglund to the Board of Directors

Published on 2012-03-12 09:15:00

CARLSBAD, Calif. (March 12, 2012) – International Stem Cell Corporation (OTCBB:ISCO) www.internationalstemcell.com, a California-based biotechnology company focused on therapeutic, cosmetic and research products, announced today that it had obtained new capital financing and made important changes in the composition of its Board of Directors to ensure that Independent Directors hold the majority of Board seats.The financing consists of $5 million in newly issued Series G Convertible Preferred [..] > read more

International Stem Cell Corporation to Present at the Roth Conference on March 14, 2012

Published on 2012-03-07 08:41:00

International Stem Cell Corporation (OTCBB:ISCO) today announced that Co-Chairman Kenneth Aldrich and President and Chief Operating Officer Kurt May will be presenting at the 24th Annual Roth Conference on Wednesday, March 14, 2012 at 1:00 p.m. Pacific time. The conference is being held March 11-14 at the Ritz Carlton Hotel in Dana Point, California.About International Stem Cell CorporationInternational Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic ste [..] > read more

PRWEB: Absorption Systems Expands In Vivo Drug and Medical Device Testing Capabilities

Published on 2012-02-01 10:18:00

Preclinical contract research organization renovates facility, adding state-of-the-art technology and upgrading ocular testing services.Exton, PA (PRWEB) January 31, 2012Absorption Systems announces the latest in a series of milestones in the continuing expansion of its AAALAC-accredited and GLP-compliant facility in San Diego, CA. The facility is undergoing extensive renovations to upgrade and expand the company’s in vivo testing capabilities for drugs and medical devices, including the const [..] > read more

International Stem Cell Corporation - "How Is Parthenogenesis Done?"

Published on 2011-12-29 10:40:00

San Diego Research Ethics ConsortiumSalk Institute for Biological StudiesParthenogenetic stem cell lines: Ethical considerationsInternational Stem Cell’s Director of Research and Therapeutic Development, Nikolay Turovets, PhD, presents “How is Parthenogenesis Done?”How is Parthenogenesis Done? (ANIMATED) > read more

RegBlog: Over-Regulation of Parthenotes Stifles Valuable Scientific Research - by Sean J. Kealy

Published on 2011-12-16 10:38:00

A recent article in Scientific American questioned whether research on stem cell lines derived from unfertilized eggs was too tightly regulated by the federal government. Now that technology allows the creation of stem cells without fertilization, there is no question that federal laws and guidelines are overly restrictive, causing a detrimental effect on valuable scientific inquiry. Since 1996, Congress has included the Dickey-Wicker Amendment in the annual federal budget. This amendment was [..] > read more

Fox News: Stem Cell Cream Shows Benefits Similar to Collagen Injections

Published on 2011-12-15 14:32:00

Watch the latest video at <a href="http://video.foxnews.com">video.foxnews.com</a>Could a stem cell skin care line be coming to a store near you?Researchers from the International Stem Cell Corporation said they have discovered a new class of pluripotent stem cells that have the same characteristics as embryonic stem cells – [..] > read more

Human Parthenogenetic Stem Cell Derived Neuronal Cells as a Tool for Parkinson’s Disease Treatment by Dr. Ruslan Semechkin

Published on 2011-12-14 11:05:00

Human Parthenogenetic Stem Cell Derived Neuronal Cells as a Tool for Parkinson’s Disease Treatment by Dr. R... > read more

International Stem Cell Corporation to Present at the 4th Annual LD MICRO Growth Conference on December 8th

Published on 2011-12-01 10:23:00

International Stem Cell Corporation (OTCBB:ISCO) today announced that Co-Chairman Ken Aldrich and President and Chief Operating Officer Kurt May will be presenting at the 4th Annual LD MICRO Growth Conference in Los Angeles on Thursday, December 8, 2011 at 2:30 p.m. Pacific. The conference is being held at the Luxe Sunset Boulevard Hotel.LD Micro founder Chris Lahiji stated, "We are excited to host over 100 companies for the first time in our history. What makes us especially proud, however, are [..] > read more

International Stem Cell Corporation to Present Immune Matching Research Advances at Cell Science and Stem Cell Research 2011 Conference

Published on 2011-11-29 10:39:00

Executives from International Stem Cell Corporation (OTCBB:ISCO), a biotechnology company specializing in the research and development of stem cell-based therapies, will be presenting advances made in its research programs related to the use of immune-matched patient-specific parthenogenetic stem cells for neurological applications and genetic liver diseases at Cell Science 2011 in Philadelphia on November 29th.Vice President Ruslan Semechkin, Ph.D., will open the conference and discuss the late [..] > read more

LifeLine Skin Care’s Holiday Gift Special PLUS an Autographed Copy of John Mauldin’s “Endgame”

Published on 2011-11-28 10:44:00

Happy Holidays from Lifeline Skin Care and John Mauldin!Check Out LifeLine Skin Care’s Holiday Gift Special PLUS an Autographed Copy of John Mauldin’s “Endgame”• Lifeline Defensive Day Moisture Serum (1 oz.)• Lifeline Recovery Night Moisture Serum (1 oz.)• In a beautiful Signature Gift Box• An original, autographed copy of John Mauldin's newest book, EndgameSpecially priced at $310 ($368+ value!) Plus Free Shipping to US addresses only*The Lifeline gift box will ship on or before [..] > read more

Listen to International Stem Cell Corporation's November 17th Business Update Conference Call

Published on 2011-11-21 10:44:00

To listen to International Stem Cell Corporation's November 17th Business Update Conference Call, please click HERE > read more

International Stem Cell Corporation's Kenneth Aldrich - The Wall Street Transcript

Published on 2011-11-17 11:55:00

If trouble viewing, please click here - International Stem Cell - TWST > read more

Lifeline Cell Technology’s FibroLife Media Used to Cultivate Tissue-Engineered Blood Vessels for Cytograft Tissue Engineering

Published on 2011-06-29 18:23:00

International Stem Cell Corporation’s (ISCO) subsidiary, Lifeline Cell Technology (Lifeline), contributed a critical role in developing and manufacturing a cell culture media that is suitable to grow the blood vessels used by Cytogra > read more

International Stem Cell Corporation's Lifeline Cell Technology Subsidiary Expands Sales and Distribution While Enhancing Manufacturing Capability and Clinical Product Opportunities

Published on 2011-06-29 13:00:00

International Stem Cell Corporation (OTCBB:ISCO) (www.intlstemcell.com), the first company to perfect a method of creating human "parthenogenetic" stem cells derived from unfertilized human eggs, reports that its wholly owned subsidiary, Lifeline Cel > read more

International Stem Cell Corporation Executives to Speak at Health and Beauty Expo in New York City

Published on 2011-06-27 10:55:00

International Stem Cell Corporation (OTCBB:ISCO) announced today that Kenneth Aldrich, Chairman of the Board, and Dr. Ruslan Semechkin, President and CEO of Lifeline Skin Care® (www.lifelineskincare.com), a subsidiary of ISCO, which develops and mar > read more

Kurt May to Join International Stem Cell Corporation as Senior Vice President

Published on 2011-06-21 10:37:00

Andrey Semechkin, Ph.D., CEO of International Stem Cell Corporation (OTCBB:ISCOE) ("ISCO") announced today that Kurt May, a highly experienced senior business executive and biotechnology entrepreneur, is concluding his service as a faculty member at > read more

International Stem Cell Corporation (ISCO) Announces That Donna Queen, Former President and CEO of ZO SKIN HEALTH, the Luxury Brand Created by Zein Obagi, MD, Has Joined ISCO Executive Team

Published on 2011-06-16 10:45:00

International Stem Cell Corporation (OTCBB:ISCOE) announced today that Donna Queen has joined ISCO's executive team. Ms. Queen will be primarily responsible for ISCO's wholly owned subsidiary Lifeline Skin Care's (Lifeline) brand identity and interna > read more

International Stem Cell Corporation Discovers Method to Produce Uncontaminated Liver Cells: New Platform to Produce Various Cell Types Free From Undifferentiated, Potentially Tumorigenic, Cells

Published on 2011-06-14 10:49:00

International Stem Cell Corporation (OTCBB:ISCOE) announces the discovery of a novel, patent-pending technology to produce unlimited numbers of liver cells (hepatocytes) that are free of contamination with potentially dangerous undifferentiated cells > read more

International Stem Cell to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on June 16

Published on 2011-06-13 10:54:00

International Stem Cell Corporation (OTCBB:ISCOE) announced today that Kenneth Aldrich, Chairman, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies Virtual Conference on Thursday, Jun > read more

International Stem Cell Corporation (ISCO) Temporary Symbol Change

Published on 2011-05-26 14:37:00

In case you are wondering why the ISCO symbol has changed from ISCO.OB to ISCOE.OB, it is due to the fact that ISCO has not yet filed our Quarterly Report for the first quarter. For further details please see our Press Release from yesterday, May 25 > read more

International Stem Cell Corporation Reports First Quarter Revenue of $1.5 Million on Strong Initial Sales of Skin Care Products and Strong Growth...

Published on 2011-05-25 10:06:00

International Stem Cell Corporation Reports First Quarter Revenue of $1.5 Million on Strong Initial Sales of Skin Care Products and Strong Growth of Research Product Sales International Stem Cell Corporation (OTCBB: ISCO) (ISCO) announces that reven > read more

International Stem Cell Corporation Enrolls First Donor in Program to Create New Parthenogenetic Stem Cell Lines in the United States

Published on 2011-05-19 09:56:00

CARLSBAD, Calif. -- (May 19, 2011) -- International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, has now enrolled the first U.S.-based donor in its program to establish a bank of clinical-grade human parthenogenetic stem cells ( > read more

International Stem Cell Corporation Chairman Comments on UC San Diego Study About Therapies Using Induced Pluripotent Stem Cells

Published on 2011-05-18 10:22:00

International Stem Cell Corporation Chairman Comments on UC San Diego Study That Finds Therapies Using Induced Pluripotent Stem Cells Could Encounter Immune Rejection ProblemsScientists at the University of California, San Diego, announced last week > read more

International Stem Cell Corporation Scientists to Present Results of Recent Stem Cell Research on Central Nervous System and Liver Disease.....

Published on 2011-05-17 10:26:00

ISCO Scientists to Present Results of Recent Stem Cell Research on Central Nervous System and Liver Diseases at Annual Meeting of American Society of Gene and Cell TherapyInternational Stem Cell Corporation (OTCBB: ISCO) announced today that two of i > read more

International Stem Cell Corporation Launches New Marketing Campaign for Lifeline Skin CareTM Products

Published on 2011-05-12 11:20:00

International Stem Cell Corporation (OTCBB: ISCO) today announced the Company's near-term marketing plans for products manufactured by its Lifeline Skin Care™ (Lifeline) subsidiary. Following the highly successful launch in late 2010 of Lifeline's > read more

A Message From International Stem Cell Corporation CEO Kenneth Aldrich Regarding Ongoing Clinical Trials

Published on 2011-05-11 20:45:00

"I've had a lot of calls and emails asking me about the impact of currently ongoing clinical trials by Geron and Advanced Cell Technology. We at International Stem Cell Corporation are delighted to see companies entering clinical trials with pluripo > read more

International Stem Cell Corporation Chairman Presents Summary of Achievements at Annual Shareholders’ Meeting

Published on 2011-05-05 09:49:00

CARLSBAD, Calif. (May 05, 2011) - At the annual shareholders meeting of International Stem Cell Corporation (OTCBB:ISCO) on May 3, 2011, Kenneth Aldrich, Chairman and co-founder of ISCO conducted a presentation to shareholders that included the foll > read more

International Stem Cell Corporation Completes First Series of Pre-Clinical Testing of Hepatocytes Derived from Human Parthenogenetic Stem Cells

Published on 2011-04-26 09:07:00

Data from successful animal study using liver cells derived from human parthenogenetic stem cells to be presented at two upcoming scientific conferences Company also announces collaboration with Cedars-Sinai Medical Center for liver disease research > read more

International Stem Cell Corporation Updates on Marketing Strategy of Its Subsidiary Lifeline Skin Care

Published on 2011-04-19 10:39:00

International Stem Cell Corporation (OTCBB:ISCO) www.internationalstemcell.com, a California-based biotechnology company focused on therapeutic and research products, announced today the selection of the Richards Partners as agency of record for its > read more

Proactiveinvestors Completes First European Presentations with NeoStem and International Stem Cell Corp

Published on 2011-03-29 10:38:00

Proactiveinvestors completed its first investor forums in mainland Europe, in partnership with Milestone Media, last week, hosting presentations in Zurich and Munich with US listed companies NeoStem (AMEX:NBS) and International Stem Cell Corporation > read more

Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, will make a public appearance on March 16th, 2011 on behalf of ISCO

Published on 2011-03-10 10:08:00

OCEANSIDE, Calif. -- (March 10, 2011) -- International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that its Executive Chairman, Kenneth C. Aldrich, will present at the ROTH 23rd Annual Orange County Growth Stock > read more

International Stem Cell Corporation Receives Important Approvals Towards Creating New Parthenogenetic Stem Cell Lines in the United States

Published on 2011-03-09 09:08:00

International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving th > read more

International Stem Cell Corporation's Senior VP Jeffrey Janus Comments on "ACT Awarded Patent for Stem Cell Generation Technique"

Published on 2011-03-03 15:15:00

"The granting of this patent is an excellent step forward in the search for new techniques to derive stem cells and treat diseases with stem cell therapy. As a licensee of this technology for several of our target stem cell applications, we at Inter > read more

ACT Awarded Patent for Stem Cell Generation Technique

Published on 2011-03-03 14:12:00

Original Article Source - Mass High TechAdvanced Cell Technology Inc. has been given a patent for its nondestructive technique of obtaining human embryonic stem cell (hESC) lines. Called “single-blastomere” technology, the technique was referred > read more

International Stem Cell Corporation Updates on 2010 Initial Product Launch of its Lifeline Skin Care Products

Published on 2011-03-02 09:30:00

International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that its wholly owned subsidiary Lifeline Skin Care, Inc. ("LSC"), has now completed its evaluation of the highly successful trial launch of its new stem > read more

"A Little Egg On the Face" - LifeLine Skin Care Stem Cell Cream Article

Published on 2011-03-01 17:20:00

"A Little Egg On the Face" by Rebecca Tolin (read San Diego Magazine article here ) Women have been known to slather their faces with fruit, fish oil, foreskin (uh huh, the target of circumcision) and even the neurotoxin that causes botulism — > read more

International Stem Cell Corporation: Note From The CEO Andrey Semechkin

Published on 2011-02-16 14:28:00

"Since releasing our press release this morning announcing that ISCO.OB had successfully created enriched cell cultures that might be used to treat diabetes or liver disease, people have asked, 'What does that really mean?’ The simple answer is > read more

International Stem Cell Corporation Demonstrates Progress in the Use of Immune Matched Human Parthenogenetic Stem Cells to Promote the Development...

Published on 2011-02-16 09:21:00

International Stem Cell Corporation Demonstrates Progress in the Use of Immune Matched Human Parthenogenetic Stem Cells to Promote the Development of Therapies for Diabetes and Liver DiseasesInternational Stem Cell Corporation (OTCBB:ISCO), www.inter > read more

International Stem Cell Corporation: A Multitude Of Potential Products From Its Parthenogenesis Technology by Jason Chew

Published on 2011-02-01 12:31:00

International Stem Cell Corporation (ISCO) is at the forefront in the field of stem cell research. Its key technology is a technique to create an immortal stem cell line by activating a human egg to create stem cells without the need for fertilizatio > read more

International Stem Cell's Scientists in Collaboration with World Leading Stem Cell Experts Extend Understanding of Human Parthenogenetic Stem Cells...

Published on 2011-01-25 12:10:00

International Stem Cell's Scientists in Collaboration with World Leading Stem Cell Experts Extend Understanding of Human Parthenogenetic Stem Cells in Peer-Reviewed PublicationsInternational Stem Cell Corporation (OTCBB:ISCO), www.internationalstemce > read more

International Stem Cell Corporation Applauds Research Showing Parthenogenesis as a Potential Strategy for Treating Inherited Disease

Published on 2011-01-13 11:03:00

International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, applauds a recent announcement by researchers at Nationwide Children's Hospital showing the use of parthenogenetic stem cells as a potential strategy to treat genetic di > read more

Patient-Derived Embryonic Stem Cells Help Deliver “Good Genes” in a Model of Inherited Blood Disorder :: Nationwide Children's Hospital

Published on 2011-01-11 15:47:00

Patient-Derived Embryonic Stem Cells Help Deliver “Good Genes” in a Model of Inherited Blood Disorder :: Nationwide Children's Hospital > read more

International Stem Cell Corporation Announces Company Update Conference Call

Published on 2011-01-11 10:04:00

International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that its Chairman, Kenneth Aldrich and the CEO of its Lifeline Skin Care subsidiary, Ruslan Semechkin, PhD, will present a Webinar discussion of the Stat > read more

International Stem Cell Corporation to Present Ethical and Technical Qualities of Human Parthenogenetic Stem Cells at the Center for Ethics in Science

Published on 2010-12-28 09:47:00

International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, will lead a free public discussion highlighting the ethical considerations and medical advantages surrounding the derivation of human stem cells > read more

International Stem Cell Corporation Announces Start of Marketing Collaboration with John Mauldin for Skin Care Products

Published on 2010-12-16 13:47:00

OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO),www.internationalstemcell.com, announced today that it had launched the first phase of its previously announced joint marketing campaign with John Mauldin, the found > read more

International Stem Cell Corporation Announces $25 Million Common Stock Financing Agreement

Published on 2010-12-13 10:08:00

International Stem Cell Corporation (OTCBB:ISCO),www.internationalstemcell.com, announced today that it had entered into an agreement with Aspire Capital Fund, LLC, to provide, at the Company's sole option, up to $25 million of equity capital over th > read more

International Stem Cell Corporation Announces Commercial Sales to General Public of Its Breakthrough Stem Cell-Based Lines of Skin Care Products

Published on 2010-11-30 11:52:00

International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that the first new topical skin care products of its subsidiary, Lifeline Skin Care, are now available to the general public within the United States at > read more

International Stem Cell Corporation Announces the Commercial Launch of Its Breakthrough Stem Cell-Based Line of Skin Care Products

Published on 2010-11-16 09:43:00

International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today the commercial launch of its innovative line of topical skin care products by the company's wholly-owned subsidiary, Lifeline Skin Care ™ (www.lifeline > read more